Cardiac device-related infective endocarditis in the Czech Republic: Prospective data from the ESC EORP EURO-ENDO registry.


Journal

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
ISSN: 1804-7521
Titre abrégé: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
Pays: Czech Republic
ID NLM: 101140142

Informations de publication

Date de publication:
May 2022
Historique:
received: 19 11 2020
accepted: 01 02 2021
pubmed: 17 3 2021
medline: 20 5 2022
entrez: 16 3 2021
Statut: ppublish

Résumé

Understanding cardiac electronic device infective endocarditis epidemiology is essential for the management of this serious complication. Only monocentric and limited data have been published regarding patients in the Czech republic so far. The aim of this study was to describe the current profile, microbiology and clinical characteristics of this population. National data from the prospective ESC-EORP EURO-ENDO registry were collected. 57 consecutive patients with a diagnosis of cardiac device-related infective endocarditis (CDRIE) from 11 Czech centres were included. Staphylococcus spp. was responsible for 43.9% of isolates, whereas Culture negative endocarditis was documented in 26.3% episodes. The most frequent complications under therapy were acute renal failure (17.5%), septic shock and heart failure (both 10.5%). Extraction of device was performed in 75.4% of all patients, and the 1-year mortality was 22.5%. The high proportion of culture-negative endocarditis is alarming and warrants further investigation. Cardiac device related infective endocarditis is a serious complication with a high 1-year mortality in a highly polymorbid spectrum of patients.

Identifiants

pubmed: 33724263
doi: 10.5507/bp.2021.013
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

168-172

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: Temporal trends and causative insights. PACE - Pacing Clin Electrophysiol 2010;33:414-9.
doi: 10.1111/j.1540-8159.2009.02569.x
Greenspon AJ, Eby EL, Petrilla AA, Sohail MR. Treatment patterns, costs, and mortality among Medicare beneficiaries with CIED infection. Pacing Clin Electrophysiol 2018;41:495-503.
doi: 10.1111/pace.13300
Rizwan Sohail M, Henrikson CA, Jo Braid-Forbes M, Forbes KF, Lerner DJ. Increased long-term mortality in patients with cardiovascular implantable electronic device infections. PACE - Pacing Clin Electrophysiol 2015;38:231-9.
doi: 10.1111/pace.12518
Habib G, Lancellotti P, Erba PA, Sadeghpour A, Meshaal M, Sambola A, Furnaz S, Citro R, Ternacle J, Donal E, Cosyns B, Popescu B, Iung B, Prendergast B, Laroche C, Tornos P, Pazdernik M, Maggioni A, Gale CP, Ali Tatar-Chentir NN, Al-Mallah M, Astrom Aneq M, Athanassopoulos G, Badano LP, Benyoussef S, Calderon Aranda E, Cardim NM, Chan KL, Cosyns B, Cruz I, Edvardsen T, Goliasch G, Habib G, Hagendorff A, Hristova K, Iung B, Kamp O, Kang DH, Kong W, Matskeplishvili S, Meshaal M, Mirocevic M, Neskovic AN, Pazdernik M, Plonska-Gosciniak E, Popescu BA, Prendergast B, Raissouni M, Ronderos R, Sade LE, Sadeghpour A, Sambola A, Sengupta S, Separovic-Hanzevacki J, Takeuchi M, Tucay E, Tude Rodrigues AC, Varga A, Vaskelyte J, Yamagata K, Yiangou K, Zaky H, Granada I, Mahia M, Ressi S, Nacinovich F, Iribarren A, Fernandez Oses P, Avegliano G, Filipini E, Obregon R, Bangher M, Dho J, Cartasegna L, Plastino ML, Novas V, Shigel C, Reyes G, De Santos M, Gastaldello N, Granillo Fernandez M, Potito M, Streitenberger G, Velazco P, Casabé JH, Cortes C, Guevara E, Salmo F, Seijo M, Weidinger F, Heger M, Brooks R, Stöllberger C, Ho CY, Perschy L, Puskas L, Binder C, Rosenhek R, et al. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry. Eur Hear J - Qual Care Clin Outcomes 2019;5:202-7.
doi: 10.1093/ehjqcco/qcz018
Vlašínová J. Cardiac device-related infection - A new epidemic? Cor Vasa 2010;52:62-6.
doi: 10.33678/cor.2010.012
Bínova J, Kubánek M, Sedláček K, Krýže L, Kautzner J. Cardiac implanted electronic device-related infective endocarditis. Interv a Akutni Kardiol 2017;16:146-50.
doi: 10.36290/kar.2017.021
Jędrzejczyk-Patej E, Mazurek M, Kowalski O, Sokal A, Kozieł M, Adamczyk K, Przybylska-Siedlecka K, Morawski S, Liberska A, Szulik M, Podolecki T, Kowalczyk J, Kalarus Z, Lenarczyk R. Device-related infective endocarditis in cardiac resynchronization therapy recipients - Single center registry with over 2500 person-years follow up. Int J Cardiol 2017;227:18-24.
doi: 10.1016/j.ijcard.2016.11.029
Özcan C, Raunsø J, Lamberts M, Køber L, Lindhardt TB, Bruun NE, Laursen ML, Torp-Pedersen C, Gislason GH, Hansen ML. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study. EP Eur 2017;19:1007-14.
doi: 10.1093/europace/euw404
Aydin M, Yildiz A, Kaya Z, Kaya Z, Basarir AO, Cakmak N, Donmez I, Morrad B, Avci A, Demir K, Cagliyan EC, Yuksel M, Elbey MA, Kayan F, Ozaydogdu N, Islamoglu Y, Cayli M, Alan S, Ulgen MS, Ozhan H. Clinical Characteristics and Outcome of Cardiovascular Implantable Electronic Device Infections in Turkey. Clin Appl Thromb 2014;22:459-64.
doi: 10.1177/1076029614567310
Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: A systematic review and meta-analysis. Europace 2015;17:767-77.
pubmed: 25926473 doi: 10.1093/europace/euv053
Raatikainen MJP, Arnar DO, Merkely B, Nielsen JC, Hindricks G, Heidbuchel H, Camm J. A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association. EP Eur 2017;19:ii1-90.
pubmed: 27771552 doi: 10.1093/europace/eux258
Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003;89:577-81.
doi: 10.1136/heart.89.5.577
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Mirob JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Mas PT, Vilacosta I, Zamorano JL, Erol C, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoenb B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GYH, Mestresc CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 2015;36:3075-123.
doi: 10.1093/eurheartj/ehv319
Bluhm G, Nordlander R, Ransjö U. Antibiotic Prophylaxis in Pacemaker Surgery: A Prospective Double Blind Trial with Systemic Administration of Antibiotic Versus Placebo at Implantation of Cardiac Pacemakers. Pacing Clin Electrophysiol 1986;9:720-6.
doi: 10.1111/j.1540-8159.1986.tb05421.x
Da Costa A, Lelièvre H, Kirkorian G, Célard M, Chevalier P, Vandenesch F, Etienne J, Touboul P. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 1998;97:1791-5.
doi: 10.1161/01.CIR.97.18.1791
Pazdernik M, Baddour LM, Pelouch R. Infective endocarditis in the Czech Republic: Eight years of experience at one of the country's largest medical centers. J Heart Valve Dis 2009;18:395-400.
pubmed: 19852143
Kim DH, Tate J, Dresen WF, Papa FC, Bloch KC, Kalams SA, Ellis CR, Baker MT, Lenihan DJ, Mendes LA. Cardiac implanted electronic device-related infective endocarditis: Clinical features, management, and outcomes of 80 consecutive patients. PACE - Pacing Clin Electrophysiol 2014;37:978-85.
doi: 10.1111/pace.12452
Tarakji KG, Chan EJ, Cantillon DJ, Doonan AL, Hu T, Schmitt S, Fraser TG, Kim A, Gordon SM, Wilkoff BL. Cardiac implantable electronic device infections: Presentation, management, and patient outcomes. Hear Rhythm 2010;7:1043-7.
doi: 10.1016/j.hrthm.2010.05.016
Pazdernik M, Wohlfahrt P, Kautzner J, Kettner J, Sochman J, Stasek J, Solar M, Pelouch R, Vojacek J. Clinical predictors of complications in patients with left-sided infective endocarditis: A retrospective study of 206 episodes. Bratislava Med J 2019;120:510-5.
doi: 10.4149/BLL_2019_082
Osmonov D, Ozcan KS, Erdinler I, Altay S, Yildirim E, Turkkan C, Ekmekci A, Gungor B, Gurkan K. Cardiac device-related endocarditis: 31-Years' experience. J Cardiol 2013;61:175-80.
doi: 10.1016/j.jjcc.2012.08.019
Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Sághy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N. European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), th. Eur Heart J 2020;41:2012-32.
doi: 10.1093/eurheartj/ehaa010
Gutiérrez Carretero E, Arana Rueda E, Lomas Cabezas JM, Laviana Martínez F, Villa Gil-Ortega M, Acosta Martínez J, Pedrote Martínez A, de Alarcón González A. Infections in Cardiac Implantable Electronic Devices: Diagnosis and Management in a Referral Center. Rev Española Cardiol (English Ed 2017;70:355-62.
doi: 10.1016/j.recesp.2016.09.016
Polewczyk A, Jacheć W, Polewczyk AM, Tomasik A, Janion M, Kutarski A. Infectious complications in patients with cardiac implantable electronic devices - risk factors, prevention and prognosis. Polish Arch Intern Med 2017; 127(9):597-607. doi: 10.20452/pamw.4065
pubmed: 28724879 doi: 10.20452/pamw.4065
Del Río A, Anguera I, Miró JM, Mont L, Fowler VG, Azqueta M, Mestres CA. Surgical Treatment of Pacemaker and Defibrillator Lead Endocarditis: The Impact of Electrode Lead Extraction on Outcome. Chest 2003;124:1451-9.
pubmed: 14555579 doi: 10.1378/chest.124.4.1451

Auteurs

Jan Latal (J)

Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic.

Michal Pazdernik (M)

Department of Cardiology, IKEM, Prague, Czech Republic.
Department of Cardiology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Maria Holicka (M)

Department of Internal Medicine and Cardiology, University Hospital Brno, Czech Republic.

Radek Pelouch (R)

1st Department of Internal Medicine - Cardioangiology, Faculty Hospital in Hradec Kralove, Czech Republic.

Jiri Widimsky (J)

Department of Cardiology, Regional Hospital Liberec, Czech Republic.

Jiri Pudich (J)

Department of Cardiovascular Diseases, University Hospital in Ostrava, Czech Republic.

Radek Vancata (R)

Department of Cardiology, University Hospital Pilsen and Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.

Michal Siranec (M)

2nd Department of Internal Cardiovascular Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic.

Kamila Blechova (K)

Cardiocenter, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Department of Cardiac Surgery, Na Homolce Hospital, Prague, Czech Republic.

Tadeas Butta (T)

Department of Cardiology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

Marketa Mikulcova (M)

Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic.

Michal Mikulica (M)

Cardiovascular Center for Adults, Tomas Bata Regional Hospital, Zlin, Czech Republic.

Peter Wohlfahrt (P)

Center for Cardiovascular Prevention, 1st Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czech Republic.

Martin Hutyra (M)

Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic.

Jan Precek (J)

Department of Internal Medicine I - Cardiology, University Hospital Olomouc, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH